If you have been reading about intranasal delivery and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Updated 2026-03-21. Numbers and descriptions here follow the published literature rather than marketing material.
Peptide bonds are vulnerable to protease attack, and Selank is no exception. Measured half-life in serum is short, on the order of minutes in several reports, which explains why intranasal administration is the common route described in the literature. Absorption across the nasal mucosa partially bypasses first-pass hepatic metabolism. Quantitative data on human bioavailability remain limited and are difficult to compare across studies.
Lyophilised material kept dry at minus 20 degrees Celsius or colder is the most stable form, and suppliers commonly state a shelf life of two years or more under those conditions. Once dissolved, degradation accelerates through hydrolysis and deamidation, particularly at alkaline pH or elevated temperature. Working solutions are usually divided into single-use aliquots to avoid repeated freeze-thaw cycles. The choice of reconstitution solvent affects both stability and the ionic strength of the final preparation.
Reverse-phase high-performance liquid chromatography with ultraviolet detection near 214 nanometres is the standard purity method. Mass spectrometry, typically electrospray ionisation, confirms identity through the expected mass-to-charge pattern. Amino acid analysis can verify composition independently. Chiral purity requires separate techniques such as derivatisation followed by chromatographic separation, and such data are rarely reported for research-grade material.
Published work on this peptide almost always uses intranasal delivery, with drops or a spray applied to the nasal mucosa. Some animal experiments have used subcutaneous or intraperitoneal injection, and a smaller number have compared routes directly. Oral administration is not a focus of the literature, because short peptides of this size are broken down by digestive enzymes and cross intestinal barriers poorly. How much of an intranasal dose reaches the bloodstream intact in humans remains an open question.
Animal studies have examined behaviour in tests of anxiety, memory retention and stress response, and several report changes in neurotrophic or neurotransmitter-related markers. The human evidence base is much smaller, consisting mainly of short trials conducted in Russia with limited reporting in English-language journals. Sample sizes are modest and outcome measures vary between studies, so the findings are best described as preliminary. Independent replication under modern trial standards has not been widely reported.
Outside its country of origin the compound is generally handled as a research chemical rather than an approved medicine. No regulatory approval from the United States Food and Drug Administration or the European Medicines Agency has been granted for human use. Identity and purity are normally checked by reverse-phase high-performance liquid chromatography, with mass spectrometry used to confirm the molecular mass. Lyophilised material is stored cold and desiccated, and repeated freeze-thaw cycles are avoided.
| Property | Value | Notes |
|---|---|---|
| Dry storage temperature | -20 C or below | Sealed, desiccated, protected from light |
| Solution stability | Hours to days at 2-8 C | Depends on buffer and microbial load |
| Preferred pH range | Near neutral to slightly acidic | Alkaline pH accelerates hydrolysis |
| Main degradation routes | Hydrolysis and deamidation | No cysteine or methionine in sequence |
| Identity confirmation | Electrospray mass spectrometry | Observed mass compared with 751.9 Da |
Proposed mechanisms center on modulation of the GABA system, but no single molecular target has been confirmed. Rodent studies report changes in GABA-A receptor expression and in the turnover of serotonin, dopamine, and norepinephrine in several brain regions. Increases in brain-derived neurotrophic factor and its receptor have also been described after repeated administration. These findings come largely from animal models, and the degree to which they describe human neurochemistry remains an open question. The mechanism is best characterized as multi-system and not fully resolved.
Pharmacokinetic data are limited. Like most short peptides, Selank is vulnerable to plasma and tissue peptidases, and its measured half-life in circulation is short, on a minutes scale. The Pro-Gly-Pro tail slows this degradation but does not eliminate it. Intranasal administration is the route described in most reports, with absorption through the nasal mucosa and a hypothesized path into the central nervous system that avoids the blood-brain barrier. Direct measurements of human brain exposure are unavailable, so distribution claims rest on inference from animal work.
Selank is studied chiefly as an animal-model anxiolytic with proposed secondary effects on memory and immune signaling. Reported mechanisms include modulation of the GABA-A receptor complex, inhibition of enkephalin-degrading enzymes, and shifts in monoamine turnover within limbic structures. Some experiments describe increased expression of brain-derived neurotrophic factor in the hippocampus after repeated dosing. No single molecular target has been confirmed, and the peptide does not bind any receptor with the selectivity typical of a conventional small-molecule drug. Mechanism therefore remains a set of hypotheses rather than an established pathway.
Laboratory work relies on standard behavioral paradigms. Rodents are tested in the elevated plus maze, open field, and passive avoidance tasks, with outcomes compared against diazepam or vehicle controls. Intranasal dosing is used most often because it bypasses first-pass metabolism, though intraperitoneal and intravenous routes also appear in published protocols. Biochemical endpoints include tissue BDNF concentrations, cytokine levels, and monoamine metabolites. Human data are limited to small Russian trials reporting reduced anxiety scores; most were not prospectively registered, and few employed independent outcome assessment.
== Case study == In 1988, Summons et al. studied the Proterozoic Kwagunt Formation of the Chuar Group in Grand Canyon, Arizona. This sedimentary rock is 850 million years old. After performing an extraction of the rocks with organic solvents, Summons characterized the abundance of various lipid biomarkers using GC-MS/MS, as described above. Using the 412-->191 m/z transition, they identified gammacerane in the extract. Summons interpreted this signal as the diagenetic product of tetrahymanol. At the time, this lipid had only been observed in protozoa, mainly ciliates. They interpreted it as a biomarker for the existence of protozoa in the Neoproterozoic. This report is still the oldest observation of gammacerane in the rock record.
=== Radioprotectors === A radioprotector is a pharmacon that, when administered, selectively protects healthy cells from the toxic effects of ionizing radiation. The first work with radioprotectors began as part of the Manhattan Project, a military research project to develop and build an atomic bomb.
HVEC's first product line targeted cancer treatment, an application that demonstrated the practical value of controlled particle acceleration for medicine. Between 1948 and 1969, the company manufactured compact 2-megavolt electron accelerators designed for hospital radiotherapy departments. These 8-foot-long generators could be operated by technicians and nurses, making radiation therapy accessible beyond major research hospitals. During their production run, 35 U.S. hospitals and eight hospitals abroad installed the machines for cancer treatment. The generators addressed significant limitations in available cancer treatments. Traditional radiotherapy relied on radium sources, which were expensive, scarce, and produced uncontrolled radiation that damaged healthy tissue surrounding tumors. Low-voltage (0.25 MV) x-ray devices were available, but lacked sufficient penetration to treat deep tumors and caused violent skin reactions. HVEC's 1- and 2-MV Van de Graaff accelerators generated artificial X-rays that could be precisely aimed and modulated, allowing physicians to target deep-seated tumors while minimizing exposure to surrounding organs. The beam energy could be adjusted to match tumor depth, and therapy could be spread across multiple sessions to reduce side effects. HVEC also supported medical research.
Sources: en.wikipedia.org
=== CNO-I === The first proposed catalytic cycle for the conversion of hydrogen into helium was initially called the carbon–nitrogen cycle (CN-cycle), also referred to as the Bethe–Weizsäcker cycle in honor of the independent work of Carl Friedrich von Weizsäcker in 1937–38 and Hans Bethe. Bethe's 1939 papers on the CN-cycle drew on three earlier papers written in collaboration with Robert Bacher and Milton Stanley Livingston and which came to be known informally as Bethe's Bible. It was considered the standard work on nuclear physics for many years and was a significant factor in his being awarded the 1967 Nobel Prize in Physics. Bethe's original calculations suggested the CN-cycle was the Sun's primary source of energy. This conclusion arose from a belief that is now known to be mistaken, that the abundance of nitrogen in the sun is approximately 10%; it is actually less than half a percent. The CN-cycle, named as it contains no stable isotope of oxygen, involves the following cycle of transformations:
== External links == Official website Advanced Drug Delivery Reviews, Interviews, http://media.journals.elsevier.com/content/files/addrmagazine-10132810.pdf https://bioscience.utah.edu/faculty/kopecek/index.php Kopeček] on bioscience.utah.edu
In 1884, Svante Arrhenius attributed the properties of acidity to hydrogen cations (H+), later described as protons or hydrons. An Arrhenius acid is a substance that, when added to water, increases the concentration of H+ ions in the water. Chemists often write H+(aq) and refer to the hydrogen cation when describing acid–base reactions but the free hydrogen nucleus, a proton, does not exist alone in water, it exists as the hydronium ion (H3O+) or other forms (H5O2+, H9O4+). Thus, an Arrhenius acid can also be described as a substance that increases the concentration of hydronium ions when added to water. Examples include molecular substances such as hydrogen chloride and acetic acid. An Arrhenius base, on the other hand, is a substance that increases the concentration of hydroxide (OH−) ions when dissolved in water. This decreases the concentration of hydronium because the ions react to form H2O molecules:
Sources: en.wikipedia.org
=== Pharmacodynamics === In vitro, cannabidiol has low affinity for, and acts as a negative allosteric modulator of the CB1 cannabinoid receptor Cannabidiol may be an antagonist of GPR55, a G protein-coupled receptor and putative non-homologous CB3 cannabinoid receptor shown by in vitro studies to be widely distributed in the brain. Cannabidiol may interact with various neurotransmitters, such as serotonin, dopamine, and GABA. As of 2024, the cellular effects and mechanisms of cannabidiol in vivo are unknown, as research to date has been inconclusive and based on laboratory studies. The anticonvulsant effects provided by cannabidiol (Epidiolex) in people with certain forms of epilepsy do not appear to involve cannabinoid receptors. A possible mechanism for the effects of cannabidiol on seizures is by affecting the neuronal movement of calcium in brain structures involved in the excessive electrical activity of seizures.
Located close to the city centre, the university campus stretches along the River Corrib. The oldest part of the university, the Quadrangle with its Aula Maxima, was designed by John Benjamin Keane in a Tudor Gothic architectural style and was constructed from local limestone; it is a replica of Christ Church, one of the colleges at the University of Oxford. The Queen's University was dissolved on 3 February 1882 under the University Education (Ireland) Act 1879, and was replaced by the Royal University of Ireland (RUI), which had been established on 27 April 1880. Under the Irish Universities Act 1908, the RUI was dissolved and was replaced by the National University of Ireland (NUI) and Queen's University of Belfast (QUB). The name of Queen's College, Galway, was changed to University College, Galway (UCG), and it became a constituent college of the new National University of Ireland, together with University College Dublin (UCD), and University College Cork (UCC). Queen's College, Belfast, became an independent university, called the Queen's University of Belfast. University College, Galway (UCG), was given special statutory responsibility under the University College Galway Act 1929 with respect of the use of the Irish language as a working language of the university. Members of the Franciscan Order from St. Anthony's College would have studied for degrees in UCG, similarly members of the Society of African Missions at their House of Philosophy, at Cloughballymore, Kilcolgan, Co Galway, studied for degrees in UCG. St. Anthony's is now used by the J.E.
== Redox reactions in industry == Cathodic protection is a technique used to control the corrosion of a metal surface by making it the cathode of an electrochemical cell. A simple method of protection connects protected metal to a more easily corroded "sacrificial anode" to act as the anode. The sacrificial metal, instead of the protected metal, then corrodes. Oxidation is used in many industries, such as in the production of cleaning products and oxidizing ammonia to produce nitric acid, whose principal industrial route is the catalytic oxidation of ammonia in the Ostwald process. Redox reactions are the foundation of electrochemical cells, which can generate electrical energy or support electrosynthesis. Metal ores often contain metals in oxidized states, such as oxides or sulfides, from which the pure metals are extracted by smelting at high temperatures in the presence of a reducing agent. The process of electroplating uses redox reactions to coat objects with a thin layer of a material, as in chrome-plated automotive parts, silver plating cutlery, galvanization and gold-plated jewelry.
Sources: en.wikipedia.org
Dry powder is best kept sealed, protected from light, and held at minus 20 degrees Celsius or below. Desiccant packaging helps limit moisture uptake because the material is hygroscopic. A sealed vial should be allowed to equilibrate to room temperature before opening to reduce condensation.
Hydrolysis of peptide bonds and deamidation of arginine and proline residues are the main degradation routes. Alkaline pH and higher temperatures accelerate both processes. Buffered, near-neutral solutions stored cold generally degrade more slowly than unbuffered ones.
Reverse-phase chromatography gives the clearest single view of related impurities and truncated sequences. Mass spectrometry then confirms that the main peak carries the expected mass. Neither test detects enantiomeric impurities, which require a separate chiral assay.
Most published work uses intranasal application, either as drops or as a nasal spray. Injection routes appear in a smaller set of animal experiments. Oral use is uncommon in the literature because peptide breakdown and poor absorption limit this route.